GOGETTERLIFESTYLEBRAND

Rep. Kim Schrier (D-Wash.) accused Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. of lying to Sen. Bill Cassidy (R-La.) when he told the senator he would maintain a key federal vaccine advisory committee “without changes.” During a budget hearing held by the House Energy and Commerce Subcommittee on Health, Schrier, a pediatrician, described the dire impacts of skipping childhood vaccinations for illnesses, such as whopping cough. “You…

A House Energy and Commerce Subcommittee on Health hearing came to a brief halt Tuesday as the Republican chair asked Health and Human Services Secretary Robert F. Kennedy Jr. to retract his accusations that a Democratic member’s stance on vaccines was influenced by campaign contributions from pharmaceutical companies. Kennedy appeared before the subcommittee to defend the Trump administration’s budget request, which includes steep cuts to the Department of Health and…

Sen. Bill Cassidy (R-La.) called for the delay of this week’s meeting of a federal vaccine advisory panel handpicked by Health and Human Services Secretary Robert F. Kennedy Jr., citing concerns about members’ lack of experience and potential bias against vaccines. “Wednesday’s meeting should not proceed with a relatively small panel, and no CDC [Centers for Disease Control and Prevention] Director in place to approve the panel’s recommendations,” Cassidy wrote…

Federal health officials on Monday touted pledges they have received from the health insurance industry to streamline and reform the prior authorization process for Medicare Advantage, Medicaid Managed Care and Affordable Care Act Health Insurance Marketplace plans which account for most insured Americans. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and Centers for Medicare & Medicaid Services Administrator Mehmet Oz took part in a roundtable discussion with…

Drugmaker Novo Nordisk said it is halting its agreement with telehealth company Hims & Hers after less than two months, citing deceptive marketing and the selling of knock-off versions of its blockbuster weight-loss drug Wegovy.  The company in April announced it would be partnering with Hims & Hers as well as other telehealth companies to sell Wegovy at a reduced cost of $499. The telehealth companies sold cheaper compounded versions of…